In terms of cost, I think it's honestly something we're not talking about. We are in the midst of a revolution of highly effective and highly expensive new genetic drug treatments and just general drug treatments, including genetic drug treatments. GLP1s are the tip of the iceberg.Insurers are going to face some very difficult decisions about drugs which are really miraculous, doing incredible things, but are also very expensive. In terms of coverage, the most acute problem is the expiration of the subsidie ...

Private Medicaid insurers list big networks of doctors to help get billions of taxpayer dollars. Many of those doctors don't actually see Medicaid patients. https://t.co/sXvTNXiUKB ...

A New York judge ruled Ron Perelman was not entitled to $400 million from insurers over alleged damage to an Andy Warhol and four other paintings from a 2018 fire at his Hamptons home https://t.co/1XpFjhMPBY ...